Figure: CRP ELISA KitStrengthening our leadership position in immunoassays, Enzo Life Sciences now offers CRP ELISA Kit – a rapid ELISA for the detection of the C-reactive Protein.
C-Reactive Protein (CRP) is a pentraxin family protein that is widely used as a biomarker for systemic inflammation and tissue injury. Its primary role in innate immunity is to function as an opsonin for pathogens via activation of the complement pathway and through binding to Fc gamma receptors. In response to infection, the serum CRP concentration can increase by up to 1000 fold. Elevated CRP levels have been reported in patients with infection, chronic inflammatory disorders, myocardial infarction, pulmonary disorders, atherosclerosis, cancer, metabolic syndrome, and depression.
The CRP ELISA Kit can be used to quantify human C-reactive protein in serum and plasma samples. This sensitive assay is fully quantitative, with the ability to detect as low as 12.625 ng/ml of C-reactive protein, surpassing semi-quantitative Western blot analysis. This assay produces rapid results in just under 2 hours with negligible reactivity to similar family member, human serum amyloid P component.
For more information, or to order the CRP ELISA Kit or other Enzo Life Sciences products, please visit us at www.enzolifesciences.com or call us at 1-800-942-0430.
Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. The company is focused on providing innovative life science research reagents worldwide based on over 30 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.
Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. Our strong portfolio of assay kits, libraries, proteins, antibodies, peptides, and small molecules provides life science researchers tools for target identification/validation, drug discovery, cellular analysis, high content analysis, gene expression analysis, nucleic acid detection, and protein biochemistry and detection.
New Product Release
Date: August 13th, 2014
For additional Information, please contact:
Kara Cannon, Global Head of Marketing
1-631-694-7070 x 145
